Revenue | ₹89.58Cr |
Net Profits | ₹8.52Cr |
Net Profit Margins | 9.51% |
Beta Drugs Ltd’s revenue jumped 0.36% since last year same period to ₹89.58Cr in the Q3 2025-2026. On a quarterly growth basis, Beta Drugs Ltd has generated -15.78% fall in its revenue since last 3-months.
Beta Drugs Ltd’s net profit fell -4.8% since last year same period to ₹8.52Cr in the Q3 2025-2026. On a quarterly growth basis, Beta Drugs Ltd has generated -30.28% fall in its net profits since last 3-months.
Beta Drugs Ltd’s net profit margin fell -5.14% since last year same period to 9.51% in the Q3 2025-2026. On a quarterly growth basis, Beta Drugs Ltd has generated -17.21% fall in its net profit margins since last 3-months.
The revenue for Beta Drugs Ltd in the Q3 results 2025 was ₹89.58Cr.
The net profit for Beta Drugs Ltd in the Q3 results 2025 was ₹8.52Cr.
The net profit margin for Beta Drugs Ltd in the Q3 results 2025 was 9.51%.
The revenue for Beta Drugs Ltd in the Q3 results 2024 was ₹89.26Cr.
The net profit for Beta Drugs Ltd in the Q3 results 2024 was ₹8.95Cr.
The net profit margin for Beta Drugs Ltd in the Q3 results 2024 was 10.03%.